Cargando…
TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia
BACKGROUND: Cancer cells show increased glycolysis and take advantage of this metabolic pathway to generate ATP. The TP53-induced glycolysis and apoptosis regulator (TIGAR) inhibits aerobic glycolysis and protects tumor cells from intracellular reactive oxygen species (ROS)-associated apoptosis. How...
Autores principales: | Qian, Sixuan, Li, Jianyong, Hong, Ming, Zhu, Yu, Zhao, Huihui, Xie, Yue, Huang, Jiayu, Lian, Yun, Li, Yanru, Wang, Shuai, Mao, Jianping, Chen, Yaoyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123356/ https://www.ncbi.nlm.nih.gov/pubmed/27884166 http://dx.doi.org/10.1186/s13045-016-0360-4 |
Ejemplares similares
-
Decitabine Downregulates TIGAR to Induce Apoptosis and Autophagy in Myeloid Leukemia Cells
por: Li, Lanzhu, et al.
Publicado: (2021) -
MiR-652-5p elevated glycolysis level by targeting TIGAR in T-cell acute lymphoblastic leukemia
por: Liu, Shan, et al.
Publicado: (2022) -
High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia
por: Song, Ying, et al.
Publicado: (2019) -
Acute promyelocytic leukemia relapsing into acute myeloid leukemia-M2 with normal cytogenetics
por: Sahoo, Ranjit Kumar, et al.
Publicado: (2013) -
Molecular Mutations and Their Cooccurrences in Cytogenetically Normal Acute Myeloid Leukemia
por: Wang, Mengning, et al.
Publicado: (2017)